Speaker Bio – May 14 meeting of the Committee on Prevention of Mental Disorders and Substance Abuse Among Children, Youth, and Young Adults

MEYER GLANTZ, Ph.D. is currently the Associate Director for Science of the Division of Epidemiology and Prevention Research (DESPR) of the National Institute on Drug Abuse, National Institutes of Health. At NIDA, Dr. Glantz has previously served as the Acting Deputy Director of DESPR and the Chief of the Epidemiology Research Branch and the Director of the Etiology Research Program.  Prior to coming to NIDA he worked as a researcher and clinician at the Veterans Administration Clinic in Boston. Dr. Glantz is a Fellow of the American Psychological Association and serves as a consultant to and board member of a variety of scientific and professional organizations and publications.  He is the author of numerous articles and chapters on substance abuse, drug abuse etiology, cognitive therapy, prevention, and developmental psychopathology and has edited several volumes including: Vulnerability to Drug Abuse; Biobehavioral Research Approaches to Drug Abuse Etiology; Resilience and Development: Positive Life Adaptations; and Drug Abuse: Origins and Interventions.  In addition, he maintains a private clinical practice in the Washington D.C. area, supervises other clinicians, and has taught at several area universities. Dr. Glantz received his doctorate from Harvard University in 1979.